A detailed history of Emerald Mutual Fund Advisers Trust transactions in Cv Rx, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 385,034 shares of CVRX stock, worth $4.02 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
385,034
Previous 329,081 17.0%
Holding current value
$4.02 Million
Previous $10.3 Million 32.23%
% of portfolio
0.39%
Previous 0.58%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$17.99 - $30.49 $1.01 Million - $1.71 Million
55,953 Added 17.0%
385,034 $7.01 Million
Q4 2023

Feb 05, 2024

SELL
$11.67 - $33.01 $1.19 Million - $3.36 Million
-101,763 Reduced 23.62%
329,081 $10.3 Million
Q3 2023

Oct 26, 2023

BUY
$13.56 - $18.47 $227,916 - $310,443
16,808 Added 4.06%
430,844 $6.54 Million
Q2 2023

Aug 10, 2023

BUY
$8.57 - $15.44 $503,873 - $907,794
58,795 Added 16.55%
414,036 $6.39 Million
Q1 2023

May 04, 2023

BUY
$7.08 - $19.4 $1.67 Million - $4.59 Million
236,471 Added 199.1%
355,241 $3.31 Million
Q4 2022

Feb 03, 2023

BUY
$10.07 - $18.35 $303,509 - $553,069
30,140 Added 34.01%
118,770 $2.18 Million
Q3 2022

Oct 25, 2022

SELL
$6.12 - $9.5 $191,274 - $296,913
-31,254 Reduced 26.07%
88,630 $827,000
Q2 2022

Jul 29, 2022

SELL
$4.7 - $7.22 $1.18 Million - $1.82 Million
-251,522 Reduced 67.72%
119,884 $721,000
Q1 2022

Apr 29, 2022

SELL
$5.62 - $12.37 $512,622 - $1.13 Million
-91,214 Reduced 19.72%
371,406 $2.23 Million
Q4 2021

Feb 02, 2022

SELL
$10.65 - $18.61 $313,110 - $547,134
-29,400 Reduced 5.98%
462,620 $5.66 Million
Q3 2021

Oct 28, 2021

BUY
$14.65 - $26.07 $3.39 Million - $6.04 Million
231,740 Added 89.03%
492,020 $8.14 Million
Q2 2021

Jul 29, 2021

BUY
$28.0 - $28.0 $7.29 Million - $7.29 Million
260,280 New
260,280 $7.29 Million

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $215M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.